HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A novel geranylated derivative, ethyl 3-(4'-geranyloxy-3'-methoxyphenyl)-2-propenoate, synthesized from ferulic acid suppresses carcinogenesis and inducible nitric oxide synthase in rat tongue.

AbstractOBJECTIVES:
We have previously observed the inhibitory effect of ferulic acid on rat tongue carcinogenesis. In this study, we investigated the modifying effects of a novel geranylated derivative, ethyl 3-(4'-geranyloxy-3'-methoxyphenyl)-2-propenoate (EGMP), synthesized from ferulic acid on tongue carcinogenesis initiated with 4-nitroquinoline 1-oxide (4-NQO).
METHODS:
F344 male rats except those treated with EGMP alone and untreated rats were given 20 ppm 4-NQO in drinking water for 9 weeks to induce tongue neoplasms. Starting 1 week after the cessation of exposure to 4-NQO, the experimental groups given 4-NQO and a basal diet were fed the experimental diets containing EGMP (0.2% and 2%) for 20 weeks. The activities of glutathione S-transferase (GST) and quinone reductase (QR), the expression of proliferating cell nuclear antigen, polyamine content and ornithine decarboxylase activity in the tongue were examined for mechanistic analysis of modifying effects of EGMP on carcinogenesis. The expression of inducible nitric acid synthase (iNOS) was also assessed immunohistochemically.
RESULTS:
At week 30, the incidence and multiplicity of tongue squamous cell carcinoma were significantly reduced by feeding of a 2% EGMP diet. EGMP feeding (2% in diet) elevated tongue GST activity and lowered QR activity in the tongue. Dietary EGMP decreased the expression of cell proliferation biomarker expression. Interestingly, EGMP feeding altered iNOS expression in the invasive parts of carcinoma.
CONCLUSIONS:
These results suggest that EGMP, when given at the 2% dose level during the promotion phase, exerts a chemopreventive action against tongue tumorigenesis through modification of cell proliferation activity and/or detoxifying enzymatic activity.
AuthorsTakuji Tanaka, Hiroyuki Kohno, Eisaku Nomura, Hisaji Taniguchi, Takuo Tsuno, Hiroyuki Tsuda
JournalOncology (Oncology) Vol. 64 Issue 2 Pg. 166-75 ( 2003) ISSN: 0030-2414 [Print] Switzerland
PMID12566915 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright 2003 S. Karger AG, Basel
Chemical References
  • 4-nitroquinolone-1-oxide
  • Biomarkers, Tumor
  • Carcinogens
  • Coumaric Acids
  • Free Radical Scavengers
  • Proliferating Cell Nuclear Antigen
  • Quinolones
  • Terpenes
  • ethyl-3-(4'-geranyloxy-3'-methoxyphenyl)-2-propenoate
  • 4-Nitroquinoline-1-oxide
  • ferulic acid
  • Nitric Oxide Synthase
  • Nitric Oxide Synthase Type II
  • Nos2 protein, rat
Topics
  • 4-Nitroquinoline-1-oxide
  • Animals
  • Biomarkers, Tumor (analysis)
  • Carcinogens
  • Cell Division (drug effects)
  • Coumaric Acids (pharmacology)
  • Free Radical Scavengers (pharmacology)
  • Gene Expression Regulation, Enzymologic (drug effects)
  • Gene Expression Regulation, Neoplastic (drug effects)
  • Immunohistochemistry
  • Incidence
  • Male
  • Nitric Oxide Synthase (analysis, antagonists & inhibitors)
  • Nitric Oxide Synthase Type II
  • Proliferating Cell Nuclear Antigen (analysis)
  • Quinolones
  • Rats
  • Rats, Inbred F344
  • Terpenes (chemical synthesis, pharmacology)
  • Tongue Neoplasms (chemically induced, enzymology, prevention & control)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: